Kymriah 欧盟 - 斯洛文尼亚文 - EMA (European Medicines Agency)

kymriah

novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - drugi antineoplastiki - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.

SMOFKABIVEN NUTRIBASE 罗马尼亚 - 罗马尼亚文 - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

smofkabiven nutribase

fresenius kabi ab - suedia - combinatii - emulsie perf. - solutii pentru administrare intravenoasa solutii pentru alimentatie parenterala